|
HS Code |
411133 |
| Chemical Name | 2-Chloromethyl-5-(4-Methylphenyl)-1,3,4-Oxadiazole |
| Molecular Formula | C10H9ClN2O |
| Molecular Weight | 208.65 g/mol |
| Cas Number | 101510-92-1 |
| Appearance | White to off-white solid |
| Melting Point | 108-112 °C |
| Solubility | Soluble in organic solvents like DMSO, DMF |
| Smiles | CC1=CC=C(C=C1)C2=NN=C(O2)CCl |
| Inchi | InChI=1S/C10H9ClN2O/c1-7-2-4-8(5-3-7)10-12-13-9(14-10)6-11/h2-5H,6H2,1H3 |
| Storage Conditions | Store in a cool, dry place, tightly closed |
| Synonyms | 5-(4-Methylphenyl)-2-chloromethyl-1,3,4-oxadiazole |
| Hazard Statements | May cause irritation to skin, eyes, and respiratory system |
As an accredited 2-Chloromethyl-5-(4-Methylphenyl)-1,3,4-Oxadiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A 25g quantity of 2-Chloromethyl-5-(4-Methylphenyl)-1,3,4-Oxadiazole is supplied in a sealed amber glass bottle with safety labeling. |
| Shipping | **Shipping Description:** 2-Chloromethyl-5-(4-methylphenyl)-1,3,4-oxadiazole should be shipped in a tightly sealed container, protected from light and moisture. Package under inert atmosphere if required. Label as a potentially harmful organic chemical. Comply with relevant local, national, and international hazardous materials regulations. Transport with appropriate documentation and safety data sheets (SDS). |
| Storage | 2-Chloromethyl-5-(4-Methylphenyl)-1,3,4-oxadiazole should be stored in a cool, dry, and well-ventilated area, away from ignition sources and incompatible substances such as strong oxidizers. Keep the container tightly closed and protect it from light and moisture. Store in a designated chemical storage cabinet and label clearly. Handle using appropriate personal protective equipment to prevent inhalation or contact. |
Applications of 2-Chloromethyl-5-(4-Methylphenyl)-1,3,4-Oxadiazole in Industrial ManufacturingAs the original manufacturer of 2-Chloromethyl-5-(4-Methylphenyl)-1,3,4-Oxadiazole, we provide this advanced intermediate to global clients involved in high-value organic synthesis. Below, we outline real-world industrial application scenarios, each explained in terms of sector-specific use, compliance, processing stage, and resulting final products. 1. Advanced Pharmaceutical Intermediate for Antimicrobial AgentsThis oxadiazole derivative functions as a key intermediate in the synthesis of next-generation antimicrobial pharmaceuticals. Medicinal chemists incorporate it during API development to construct azole-containing drug scaffolds. Its use requires rigorous adherence to pharmaceutical regulations and it undergoes strict quality control in compliance with global cGMP and pharmacopoeial standards throughout the downstream synthesis of antimicrobial ingredients. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Active Ingredient IntermediateProducers utilize this raw material to build the oxadiazole nucleus within a range of selective herbicides and fungicides. During formulation, agrochemical companies integrate it as a key structure-blocking intermediate, which enables synthesis of high-purity actives for crop protection. Batch documentation and compliance with agrochemical-specific regulatory filings are mandatory for downstream production. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Specialty Intermediate for Electronic ChemicalsWithin the electronics sector, material formulators use the compound as a precursor to finely-tuned functional layers in photoresist and dielectric materials. Chemically, the oxadiazole unit provides controlled electronic characteristics and high stability, important during the manufacture of high-resolution circuit substrates. Compliance with electronics and semiconductor-grade purity standards is strictly required during all downstream processes. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Intermediate for Fluorescent Dye and Optical Material SynthesisThis oxadiazole analog enters the specialty dye sector as a core intermediate during the preparation of functional fluorescent dyes and optical brighteners, offering unique photophysical properties needed for security printing and specialized optical components. Dye houses and specialty chemical firms ensure compliance with relevant chemical safety, REACH, and optical material standards during downstream handling and QC. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 2-Chloromethyl-5-(4-Methylphenyl)-1,3,4-Oxadiazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Years spent in the synthesis workshop have shaped our approach to specialty heterocycles, and 2-Chloromethyl-5-(4-Methylphenyl)-1,3,4-Oxadiazole stands out with a clear place in the chemist’s toolkit. Demand for precision intermediates keeps rising, especially as pharmaceutical and agrochemical research sharpens its focus on highly functionalized molecules. This product’s molecular profile reflects the changes in how labs develop actives—visualized by committed bench chemists looking for small, selective changes to steer extensive projects.
Every barrel moving from our reactor rooms to the kiln-fitted drying areas comes with a history of deliberate control. At our plant, the typical batch specification brings this compound to market at high purity—often above 98% by HPLC. Maintaining this minimum isn’t a box to tick but a daily interaction with analytical chemists who calibrate, sample, and check every lot before it leaves our hands. Impurity control stretches well beyond spot checks because customers running scale-up trials rely on repeat outcomes. As a team, we push each batch to match the previous run’s chromatographic fingerprint while watching for trace byproducts that might hinder downstream synthesis.
Color and appearance do more than indicate quality—they signal process stability. Any slight tint or off-white appearance can cue an operator to solvent ratios that drifted by a percent or two or to thermal steps that stretched beyond optimal limits. Our teams set reproducible parameters and backtrack any outlier, learning and adapting. This attention to detail means every box shipped looks and behaves like the last one, a level of control that impacts our customer’s confidence.
Manufacturers view scale-up as more than a series of multiplication exercises. At the kilogram and ton levels, reaction exotherms can behave unpredictably. Our approach involves constant monitoring, staged temperature ramps, and regular agitation speed adjustments. We design these steps from repeated pilot runs. A single mistake—too rapid addition of chlorinating reagent, misjudged solvent concentration—leads to localized overheating or product degradation. Intimate knowledge of each reaction stage, learned through tests and sometimes failures, helps the team deliver lots that conserve the integrity of the chloromethyl group, so the product retains its full reactivity for further use.
Solvent recovery, a core part of our environmental protocol, saves costs and protects both air and water. Common solvents like DMF or toluene pass through recovery units, and spent aqueous streams enter on-site treatment cascades where organic residues get neutralized before discharge. We invest steadily in these systems because downstream users face stricter compliance regimes year after year. Our design includes not just product yield, but lifecycle control that keeps both regulators and research partners assured.
Nobody appreciates a high-purity intermediate more than the bench chemist mapping out synthetic routes for new actives. The chloromethyl group in this oxadiazole ring provides a reliable reactive handle—a gateway to further nucleophilic substitutions. Whether it serves as an anchor onto bioactive frameworks or gets elaborated into functionalized materials, it provides a leap ahead for those building complexity on a core scaffold.
We see our regular customers using 2-Chloromethyl-5-(4-Methylphenyl)-1,3,4-Oxadiazole not merely as an academic curiosity, but as a pivotal step in their process. In one example, pharmaceutical teams synthesize newer heterocyclic motifs where the oxadiazole core dovetails with other aromatic or heteroaromatic pieces. The methylphenyl ring sourced from our process often features standardized para substitution, ensuring that the steric and electronic nature of the product remains constant. Customers running parallel screenings depend on subtle differences in these substituents to tune biological activity or selectivity.
In the agrochemical sector, research teams employ this intermediate to construct lead molecules targeting specific pest and weed profiles. Here, both purity and isomeric composition make practical differences to biological readout, and mismatched starting material can cascade into wasted weeks of downstream effort. Our team fields technical calls about reactivity trends in real use conditions because we track feedback from end users, not just from our own QC.
Comparing 2-Chloromethyl-5-(4-Methylphenyl)-1,3,4-Oxadiazole to more common oxadiazoles reveals useful distinctions. Many commercial oxadiazoles offer benzylic substituents, but few combine chloromethyl reactivity with a 4-methylphenyl motif. That particular ensemble changes its chemical personality. The para-methyl group shields the ring and shifts electronic density, smoothing the way for specific alkylations and helping avoid overreaction or unwanted side products. Other chloromethylated heterocycles might deliver higher intrinsic reactivity, but risk instability—especially under heat or in the presence of common nucleophiles.
Customer feedback underscores the difference. One formulation group reported smoother coupling to amines and thiols, citing fewer byproducts and less cleanup. The oxadiazole ring imparts greater hydrolytic stability compared to open-chain analogs. This property comes in handy for teams running high-throughput reaction stacks, especially those who need consistent conversions and minimal side reactions. Our own in-process checks show that even minor changes to the methyl position or chloromethyl placement translate to measurable differences in both solubility and handling—data that trickles down to process chemists planning next-generation syntheses.
Every year, research cycles speed up. Delayed shipments or inconsistent batches can set back entire discovery programs, so stock outages are not an option from a manufacturing perspective. Our site maintains advance scheduling for both small-lot and large-batch orders, and we hold critical raw materials on reserve to guard against supply shocks. By proactively communicating with raw material suppliers, we address volatility in halogen compounds and aromatics, cutting down the risk of bottlenecks.
The challenge isn’t just about storing drums on a shelf. We structure production to handle spikes in demand without leaning on “rush” products that sacrifice analytical rigor for the sake of lead time. Each production sequence includes enough buffer to rework or purify any substandard lot—an approach that sidesteps common complaints about generic-grade material that only passes minimum spec. This attitude comes from hands-on experience. Inconsistent intermediates not only waste time on the research end; they sap trust between supplier and customer.
Every batch and every drum reflects our long learning curve, combining scrupulous raw material checks, incremental process improvements, and attention to every quality outlier. This long-term investment means even first-time buyers encounter the same reliability as partners with longstanding agreements. We emphasize direct accountability, so research programs keep moving forward without stalls caused by inconsistent sources.
Specialty intermediates rarely stand still. Regulatory changes, especially in Western and Asian markets, push manufacturers to reconsider solvent use, minimize waste, and implement greener process modifications. Over the past decade, we’ve seen an increasing shift toward halogen economy—reflecting both environmental concern and the rising costs in halogen chemistry. As the original manufacturer, we can quickly adapt process flow, swap chlorinating reagents for lower-impact routes, or pilot alternative workups that more distributors can’t match. Our teams collaborate with safety officers and regulatory specialists to update MSDS content promptly, covering not just product toxicity but the latest handling requirements.
From ongoing technical calls with formulators, we observe growing need for compatibility metrics—such as solvent carryover profiles, minor impurity patterns, and trace element listing. Engineers and lead chemists, especially those working on late-stage development, request transparency about every aspect of the isolate they’re using. Our focus on in-house analytical capacity helps us answer these questions without delay, drawing on both HPLC, NMR, and GC-MS data. Open communication keeps both sides up to date, fostering information exchange instead of surprises after delivery.
Cost pressures loom for everyone in the supply chain. As markets churn and raw material prices spike, keeping tight control over procurement contracts helps us pass price stability on to customers. We learned the hard way that no shortcut in sourcing pays off—substandard starting chlorobenzenes or toluenes always haunt final product specs. Long-term relationships with upstream producers and regular site audits help maintain quality and protect both our interests and those of downstream users.
Even a well-tuned process can run into issues. Our technical teams meet weekly to review product consistency, new impurity signals, or oddities in solubility that might escape routine QC. We’ve set up a feedback loop that includes both upstream production teams and downstream analytics. Any deviation—even a minor one in spectral verification—signals a chance to check instrumentation, recalibrate, or tweak solvent ratios. This ongoing vigilance avoids the lazy slide toward “good enough” that can creep into larger operations. Tight batch histories, retained samples, and real-time process documentation ensure that questions about a lot’s background get clear answers fast—especially crucial for users in regulated sectors like pharma and agchem.
The mindset at the plant differs from that of intermediaries who only handle product; here, accountability runs deep from the sourcing dock to the fill line. Our operators, analytical chemists, and field reps all shelter a kind of professional pride that shows in every on-spec molecule. The best solutions often trace back to open-door policies: we encourage customers to share odd outcomes, application hitches, or unexpected downstream phenomena. This way, we adapt production and analytical support in step with real-world use—not just with lab-based plans.
Supporting research doesn’t stop at batch output. We frequently support exploratory teams looking to convert the chloromethyl group to other functional motifs—amines, acids, sulfonates—each requiring distinct handling and often different purification techniques. We keep archived application notes and run custom trials to troubleshoot reactivity questions or optimize routes under customer conditions. Years in the field taught us never to underestimate the impact a single impurity or slight stereochemical preference can have on a multistep process; partnering with end-users from R&D through to larger-scale demonstration runs helps us support innovation rather than block it.
Occasionally, project leaders request ad-hoc scale-ups, process adjustments, or help with analytical interpretation beyond the standard scope. While these aren’t everyday requests, our in-house capability lets us flex resources to support such work. As a result, both multinational leaders and emerging biotech or agchem ventures take confidence in direct support that shortens their development timelines.
Few chemicals offer total stability without care. Over time, our plant teams have tracked ideal storage conditions and container types for this product. Even with robust moisture barriers, proper drum sealing and dry air headspace make a difference on shelf life—so we cycle old stock, keeping everything fresh. Bulk packaging meets the needs of formulators demanding larger lots, but smaller sealed packs move regularly for bench-scale labs. Our crew tracks container compatibility, and we switch to lined drums or special liners as research teams request lower background impurity tolerance. In-house packing lines help prevent cross-contamination, and batch tracking ensures traceability if a question ever arises.
Temperature swings and excessive humidity don’t just affect shelf life; they can shift product properties enough to throw off a synthesis. Our staff documents optimal storage, but more importantly, we audit in-warehouse conditions regularly. We keep customers ahead of potential loss in quality—reporting shelf trends, tracking returns, and issuing shelf-life reminders.
Manufacturing halogenated intermediates calls for more than just compliance; it demands continuous improvement. All routine operations at our site incorporate monitoring for airborne emissions, with in-stack scrubbers handling residual chlorinated organics. Regular water checks accompany biological treatment units designed to keep plant runoff below mandated limits. Employees operate under strict safety protocols, following lockout procedures, PPE requirements, and chemical exposure monitoring. These efforts don’t just satisfy regulators—they keep the plant running smoothly and our people safe.
Emergency scenarios, though rare, receive regular drills and root cause training. A good record with environmental agencies and industrial oversight groups hasn’t come by chance; it grows out of a culture that treats safe, reliable manufacture as a core value.
What sets one 1,3,4-oxadiazole supplier apart from another comes down to experience and track record. One can only build reliable product supply with years of investment in process oversight, skilled teams, and ongoing knowledge updates. In a world where customers demand more application support, more reproducible quality, and more transparency, the front-line experience of our operators and chemists becomes decisive.
Our guiding principle draws from past rounds of process troubleshooting, the willingness to adapt, and direct partnerships with developers who treat raw intermediates as building blocks for something new. This knowledge shapes every step of manufacturing, packaging, storage, and delivery. With open feedback, sustained investment in both people and process, and a clear view of future needs, we keep our product—not just up to spec, but up to the demands of discovery, quality, and responsible manufacture.